New Zealand King Salmon Investments Limited (NZE:NZK)
New Zealand · Delayed Price · Currency is NZD | Market Cap | 123.78M +7.0% |
| Revenue (ttm) | 176.58M -13.5% |
| Net Income | -9.49M |
| EPS | -0.02 |
| Shares Out | 538.18M |
| PE Ratio | n/a |
| Forward PE | 12.78 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 255,121 |
| Average Volume | 153,353 |
| Open | 0.2300 |
| Previous Close | 0.2300 |
| Day's Range | 0.2250 - 0.2300 |
| 52-Week Range | 0.1890 - 0.2500 |
| Beta | 0.88 |
| RSI | 61.41 |
| Earnings Date | Apr 2, 2026 |
About NZE:NZK
New Zealand King Salmon Investments Limited, together with its subsidiaries, engages in the farming, processing, sale, and distribution of salmon products in New Zealand, North America, Australia, Japan, Europe, China, and internationally. The company offers whole fish, fillets, raw portions, cold and hot smoked, wood roasted, salmon and potato cakes, caviar, oil, kibble, and pet treats, as well as ready to cook options. It is also involved in the operation of freshwater facilities that support broodstock, hatchery, and smolt production; seafar... [Read more]
Financial Performance
Financial StatementsNews
New Zealand King Salmon Investments Transcript: AGM 2026
The meeting reviewed a challenging financial period marked by a net loss and reduced harvest, but highlighted strong progress in strategic initiatives such as the wellboat lease, Blue Endeavour pilot, and advanced breeding programs. All resolutions, including the transformational wellboat transaction, were unanimously recommended by the board.
New Zealand King Salmon Investments Earnings Call Transcript: H1 2026
Net loss after tax was NZD 20.8 million, mainly due to a non-cash write-down of biological assets, while pro forma EBITDA fell to NZD 5.7 million. Management remains confident in growth, with improved outlooks for harvest volumes and continued investment in Blue Endeavour and processing capacity.
New Zealand King Salmon Investments Transcript: AGM 2025
FY2025 saw record pro forma EBITDA and strong cash generation, but net profit fell due to asset revaluation. FY2026 guidance was revised down after higher fish mortality and lower growth, prompting a focus on long-term resilience, Blue Endeavor expansion, and innovation in fish health.
New Zealand King Salmon Investments Earnings Call Transcript: H2 2025
Net profit after tax fell to NZD 13.4 million due to non-cash losses, but Pro Forma EBITDA hit a record NZD 29.7 million. FY 2026 guidance is lower, reflecting reduced harvest from elevated mortality and growth challenges, with CapEx focused on Blue Endeavour and core operations.
New Zealand King Salmon Investments Earnings Call Transcript: H1 2025
First-half pro forma EBITDA rose 26% to NZD 13.5 million, while GAAP net profit fell to NZD 6.0 million due to non-cash adjustments. Revenue grew 11% and Blue Endeavour pilot investments are progressing, with full-year EBITDA guidance set at NZD 26–30 million.